newsfilter
← Latest News
Business Wire·

Myomo Reports Second Quarter 2025 Financial and Operating Results

Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable